Neuromon B.V. is licensed for the implementation of the so-called PaR-technology.
PaR-technology is a new way to express cerebral autoregulatory state by calculating a combined index based upon the continuous registration of arterial blood pressure, as the driving force, and middle cerebral artery flow velocity, as resultant.
The so-called pulsatile apparent resistance is negative when cerebral autoregulation is exhausted. Varies between 0 and 0.6 in the normal situation and increases over 0.6 in intracranial hypertension.
In the EU, PaR-technology was filed in the Netherlands, Belgium, Great Britain, France and Germany.
Outside the EU PaR-technology was filed in the EU, USA, Canada and Australia (WO2005102158A1).
DE: 60 2005 056 940.5